655 related articles for article (PubMed ID: 27489267)
1. Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.
Manickam C; Rajakumar P; Wachtman L; Kramer JA; Martinot AJ; Varner V; Giavedoni LD; Reeves RK
J Virol; 2016 Oct; 90(20):9153-62. PubMed ID: 27489267
[TBL] [Abstract][Full Text] [Related]
2. Infection of Common Marmosets with GB Virus B Chimeric Virus Encoding the Major Nonstructural Proteins NS2 to NS4A of Hepatitis C Virus.
Zhu S; Li T; Liu B; Xu Y; Sun Y; Wang Y; Wang Y; Shuai L; Chen Z; Allain JP; Li C
J Virol; 2016 Sep; 90(18):8198-211. PubMed ID: 27384651
[TBL] [Abstract][Full Text] [Related]
3. Hepatic immunopathology during occult hepacivirus re-infection.
Manickam C; Martinot AJ; Jones RA; Varner V; Reeves RK
Virology; 2017 Dec; 512():48-55. PubMed ID: 28915405
[TBL] [Abstract][Full Text] [Related]
4. Virus-specific T-cell immunity correlates with control of GB virus B infection in marmosets.
Woollard DJ; Haqshenas G; Dong X; Pratt BF; Kent SJ; Gowans EJ
J Virol; 2008 Mar; 82(6):3054-60. PubMed ID: 18094181
[TBL] [Abstract][Full Text] [Related]
5. Infection of common marmosets with hepatitis C virus/GB virus-B chimeras.
Li T; Zhu S; Shuai L; Xu Y; Yin S; Bian Y; Wang Y; Zuo B; Wang W; Zhao S; Zhang L; Zhang J; Gao GF; Allain JP; Li C
Hepatology; 2014 Mar; 59(3):789-802. PubMed ID: 24123143
[TBL] [Abstract][Full Text] [Related]
6. GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology.
Jacob JR; Lin KC; Tennant BC; Mansfield KG
J Gen Virol; 2004 Sep; 85(Pt 9):2525-2533. PubMed ID: 15302946
[TBL] [Abstract][Full Text] [Related]
7. Immunity against the GBV-B hepatitis virus in tamarins can prevent productive infection following rechallenge and is long-lived.
Bukh J; Engle RE; Govindarajan S; Purcell RH
J Med Virol; 2008 Jan; 80(1):87-94. PubMed ID: 18041000
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA.
Martin A; Bodola F; Sangar DV; Goettge K; Popov V; Rijnbrand R; Lanford RE; Lemon SM
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9962-7. PubMed ID: 12907703
[TBL] [Abstract][Full Text] [Related]
9. IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.
Zhang S; Saha B; Kodys K; Szabo G
J Hepatol; 2013 Sep; 59(3):442-9. PubMed ID: 23665181
[TBL] [Abstract][Full Text] [Related]
10. Development of a GB virus B marmoset model and its validation with a novel series of hepatitis C virus NS3 protease inhibitors.
Bright H; Carroll AR; Watts PA; Fenton RJ
J Virol; 2004 Feb; 78(4):2062-71. PubMed ID: 14747571
[TBL] [Abstract][Full Text] [Related]
11. Host-virus interactions in hepatitis B and hepatitis C infection.
Yoshio S; Kanto T
J Gastroenterol; 2016 May; 51(5):409-20. PubMed ID: 26894594
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis.
Pollmann J; Götz JJ; Rupp D; Strauss O; Granzin M; Grünvogel O; Mutz P; Kramer C; Lasitschka F; Lohmann V; Björkström NK; Thimme R; Bartenschlager R; Cerwenka A
J Hepatol; 2018 Mar; 68(3):421-430. PubMed ID: 29100993
[TBL] [Abstract][Full Text] [Related]
13. The marmoset model of GB virus B infections: adaptation to host phenotypic variation.
Weatherford T; Chavez D; Brasky KM; Lanford RE
J Virol; 2009 Jun; 83(11):5806-14. PubMed ID: 19279089
[TBL] [Abstract][Full Text] [Related]
14. Changes in immune cell populations in the periphery and liver of GBV-B-infected and convalescent tamarins (Saguinus labiatus).
Hood SP; Mee ET; Perkins H; Bowen O; Dale JM; Almond NM; Karayiannis P; Bright H; Berry NJ; Rose NJ
Virus Res; 2014 Jan; 179(100):93-101. PubMed ID: 24246306
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence.
Chigbu DI; Loonawat R; Sehgal M; Patel D; Jain P
Cells; 2019 Apr; 8(4):. PubMed ID: 31027278
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cells in hepatitis C: Current progress.
Yoon JC; Yang CM; Song Y; Lee JM
World J Gastroenterol; 2016 Jan; 22(4):1449-60. PubMed ID: 26819513
[TBL] [Abstract][Full Text] [Related]
17. Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus.
Beames B; Chavez D; Guerra B; Notvall L; Brasky KM; Lanford RE
J Virol; 2000 Dec; 74(24):11764-72. PubMed ID: 11090176
[TBL] [Abstract][Full Text] [Related]
18. Immune function of plasmacytoid dendritic cells, natural killer cells, and their crosstalk in HBV infection.
Golsaz-Shirazi F; Amiri MM; Shokri F
Rev Med Virol; 2018 Nov; 28(6):e2007. PubMed ID: 30175481
[TBL] [Abstract][Full Text] [Related]
19. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
[TBL] [Abstract][Full Text] [Related]
20. Innate and adaptive immune responses in HCV infections.
Heim MH; Thimme R
J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
